Kaplan-Meier analysis of 1336 colon cancer patients (kmplot.com [25]) demonstrated that high expression of MAD1L1 associates with significantly worse prognosis as measured by relapse free survival (Fig 1B). This evidence concerns the gene MAD1L1 and malignant colon neoplasm.